Skip to content

Clinical trials

Psychotic Disorders trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Country / region: Brazil Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20062
20081
20091
20131
20142
20151
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
ACADIA Pharmaceuticals Inc.1
Columbia University1
Janssen Research & Development, LLC1
Janssen Scientific Affairs, LLC1
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Sumitomo Pharma America, Inc.1
Universidade Federal do Rio de Janeiro1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders13
Schizophrenia11
Alzheimer Disease1
Bipolar Disorder1
Body Weight Changes1
Depressive Disorder1
Hallucinations1
Insulin Resistance1
Schizophrenia Spectrum and Other Psychotic Disorders1
Thrombophilia1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.